Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Dilip Turbadkar"'
Autor:
Beena Joshi, Gajanan Velhal, Sanjay Chauhan, Ragini Kulkarni, Shahina Begum, Y S Nandanwar, Michelle Fonseca, Sujata Baweja, Dilip Turbadkar, Anita Ramchandran, Asha Dalal, Jayanti Shastri, Sachee Agrawal, Manisha Panhale, Vasundhara Sanap, Pravin, Renuka Panchal, Suman Kanougiya
Publikováno v:
Indian Journal of Community Medicine, Vol 40, Iss 3, Pp 168-173 (2015)
Background: Access to reproductive health services in Human Immunodeficiency Virus (HIV) programs can greatly enhance program′s potential to limit the spread of disease, reduce unintended pregnancies and safeguard the health of infected people. Obj
Externí odkaz:
https://doaj.org/article/d1cde8bcccd644e1adab6f356cb4bfa5
Publikováno v:
INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH. :22-25
Background: Women with normal cervical cytology, who are infected with high-risk HPV type, have an approximately 100-fold increased risk of developing cervical cancer compared with uninfected women. Present study was conducted to study seroprevalence
Publikováno v:
INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH. :64-67
Background: Cervical cancer is the commonest cancer amongst Indian women and the second most common cancer in the women worldwide. Persistent infection with high-risk HPV (HR-HPV) is the most important risk factor for cervical cancer precursors and i
Autor:
Balaji Veeraraghavan, Yamuna Devi Bakthavatchalam, Abi Manesh, Binesh Lal, Subramanian Swaminathan, Abdul Ansari, K. Subbareddy, Pradeep Rangappa, Anirban Hom Choudhuri, Vasant Nagvekar, Yatin Mehta, Boppe Appalaraju, Sujata Baveja, Shrikala Baliga, Suchitra Shenoy, Renu Bhardwaj, Vaishali Kongre, Gogi Suresh Dattatraya, Binita Verma, D.N. Mukherjee, Shalini Gupta, Priyadarshini Shanmugam, Jyoti Iravane, Sudhi Ranjan Mishra, Purabi Barman, Shimpi Chopra, Meenakshi Hariharan, Rajendra Surpam, Rana Pratap, Dilip Turbadkar, Shripad Taklikar
Publikováno v:
Indian Journal of Medical Microbiology. 41:71-80
Levonadifloxacin (intravenous) and alalevonadifloxacin (oral prodrug) are novel antibiotics based on benzoquinolizine subclass of fluoroquinolone, licensed for clinical use in India in 2019. The active moiety, levonadifloxacin, is a broad-spectrum an
Autor:
Anjali Swami, Ankita Mohanty, Ashima Jamwal, Dilip Turbadkar, Sujata Baveja, Jayanthi Shastri, Vidushi Chitalia
Publikováno v:
Journal of Medical Microbiology. 72
Introduction. As the world was still recovering from the 2020 pandemic, the devastating impact of Covid-19 driven by the Delta variant shook the world in 2021. As the second wave was declining, there was an unusual surge in Covid-19 positive cases by
Publikováno v:
Journal of medical microbiology. 71(6)
Introduction. India is home to the most significant number of tuberculosis (TB) cases around the globe. The COVID-19 crisis has massively affected TB healthcare services in the country. Hypothesis/Gap Statement. Are we sufficiently equipped to fight
Publikováno v:
International Journal of Current Microbiology and Applied Sciences. 6:201-206
Autor:
Chaya A. Kumar, Anita Ramchandran, Dilip Turbadkar, Mrudul Randive, Shanta Shubhra Das, Sujata Baveja
Publikováno v:
International Journal of Current Microbiology and Applied Sciences. 5:669-676
Publikováno v:
Indian Journal of Medical Microbiology, Vol 27, Iss 2, Pp 153-155 (2009)
Nine hundred and forty two serum samples from clinically suspected cases of leptospirosis admitted in Lokmanya Tilak Municipal General Hospital, Mumbai during July-September 2005 were tested by LeptoTek Dri-dot/Leptocheck. One hundred and sixty five
Autor:
Sanjay Chauhan, Pravin Sanap, Sachee Agrawal, Manisha Panhale, Vasundhara More, Y. S. Nandanwar, Beena Joshi, Sujata Baweja, Gajanan Velhal, Asha Dalal, Jayanti Shastri, Dilip Turbadkar, Suman Kanoujiya, Anita Ramachandran, Michelle Fonseca, Shahina Begum, Ragini Kulkarni, Renuka Panchal
Publikováno v:
BMC Infectious Diseases
Background The PPTCT program in India focuses on prong 3 (Provision of Nevirapine to pregnant infected mothers) and reports quote that it reaches only 32% of pregnant mothers who need it. Preventing unintended pregnancies among HIV positive women (Pr